首页> 外文期刊>Journal of viral hepatitis. >Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.
【24h】

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.

机译:希腊丙型肝炎病毒(HCV)的分子流行病学:HCV基因型特异性发生率的时间趋势和基因型4分离株的分子特征。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study aimed to estimate the overall HCV genotype distribution and to reconstruct the HCV genotype-specific incidence in Greece during the recent decades. It also focused at the identification of genotype 4 subtype variability in Greek isolates. A total of 1686 chronically infected HCV patients with detectable serum HCV RNA by RT-PCR, belonging to different risk groups were studied. Amplified products from the 5'-noncoding region were typed using a commercially available assay based on the reverse hybridization principle. The HCV genotype-specific incidence was estimated using a previously described back calculation method. HCV genotype 1 was the most prevalent (46.9%) followed by genotype 3 (28.1%), 4 (13.2%), 2 (6.9%) and 5 (0.4%). A high prevalence of genotype 1 (66.3%) in haemophilia patients was recorded whereas HCV genotype 3 was found mainly among patients infected by I.V. drug use (58.2%). Data on the temporal patterns of HCV genotype-specific incidence in Greece revealed a moderate increase (1.3-1.6 times) for genotypes 1 and 4, and a decrease (1.5 times) for genotype 2 from 1970 to 1990, whereas there was a sharp (13-fold) increase for genotype 3. The molecular characterization of 41 genotype 4 HCV isolates belonging to various risk groups revealed that, subtype 4a was the most frequently detected (78%). Phylogenetic comparison of the Greek 4a isolates with all HCV-4a isolates reported worldwide so far revealed a topology which does not discriminate Greek isolates from the others. HCV-4 does not represent a recent introduction in Greece.
机译:这项研究的目的是估计整个HCV基因型分布并重建最近几十年来希腊HCV基因型特异的发病率。它还侧重于鉴定希腊分离株的基因型4亚型变异性。总共研究了1686名通过RT-PCR检测到血清HCV RNA的慢性感染HCV患者,这些患者属于不同的风险组。基于反向杂交原理,使用可商购的测定法对来自5'-非编码区的扩增产物进行分型。 HCV基因型特异性发病率是使用先前描述的反向计算方法估算的。 HCV基因型1最普遍(46.9%),其次是基因型3(28.1%),4(13.2%),2(6.9%)和5(0.4%)。血友病患者中基因型1的患病率很高(66.3%),而HCV基因型3的发现主要是在I.V.吸毒(58.2%)。关于希腊HCV基因型特定发病率的时间模式的数据显示,从1970年到1990年,基因型1和4的适度增加(1.3-1.6倍),基因型2的适度增加(1.5倍),而基因型3增加了13倍)。41个基因型4 HCV分离株的分子特征属于不同的风险组,发现亚型4a是最常被检测到的(78%)。对希腊4a分离株与迄今全世界报道的所有HCV-4a分离株进行系统发育比较,发现该拓扑结构无法区分希腊分离株与其他分离株。 HCV-4并不代表希腊最近推出的产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号